CN1672697A - 一种治疗头痛的中药 - Google Patents

一种治疗头痛的中药 Download PDF

Info

Publication number
CN1672697A
CN1672697A CN 200410013636 CN200410013636A CN1672697A CN 1672697 A CN1672697 A CN 1672697A CN 200410013636 CN200410013636 CN 200410013636 CN 200410013636 A CN200410013636 A CN 200410013636A CN 1672697 A CN1672697 A CN 1672697A
Authority
CN
China
Prior art keywords
chinese medicine
headache
treatment
add
rhizoma chuanxiong
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410013636
Other languages
English (en)
Other versions
CN1281234C (zh
Inventor
芦天罡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIREN PHARMACEUTICAL CO Ltd HEILONGJIANG PROV
Original Assignee
QIREN PHARMACEUTICAL CO Ltd HEILONGJIANG PROV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QIREN PHARMACEUTICAL CO Ltd HEILONGJIANG PROV filed Critical QIREN PHARMACEUTICAL CO Ltd HEILONGJIANG PROV
Priority to CN 200410013636 priority Critical patent/CN1281234C/zh
Publication of CN1672697A publication Critical patent/CN1672697A/zh
Application granted granted Critical
Publication of CN1281234C publication Critical patent/CN1281234C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

一种治疗头痛的中药,由以下成分构成:川芎、荜茇,其成份的重量配比为:川芎100-140份、荜茇40-80份。本发明的中药具有温中、散寒、止痛的功能,对治疗血管性头痛、三叉神经痛有理想的效果。可广泛作为中年及老年人各类头痛病的治疗药物。

Description

一种治疗头痛的中药
技术领域:本发明涉及治疗头痛的中药,特别是治疗三叉神经痛的中药。
背景技术:目前用于治疗三叉神经痛的中药疗效都不显著,而西药治标不治本还有副作用,解决这一问题已成为急需。
发明的内容:克服现有技术存在的不足,提出一种治疗头痛的中药。该中药由以下成份构成:川芎、荜茇,其成份的重量配比为:川芎100-140份、荜茇40-80份。其制备工艺是:将以上二味药酌予碎断,加80%乙醇回流提取三次,每次2小时、分次过滤,合并滤液,并浓缩至相对密度为1.34(80℃热测)的浸膏,加入适量糖粉混匀制成软材,过12目筛制粒,70℃烘干,整粒,装入胶囊每粒0.5g,既得。本发明的中药由于含有川芎,对动物中枢神经系统有镇静的作用,川芎所含的阿魏酸与其它有效成份对平滑肌有抗痉作用。荜茇含有胡椒碱等成份、有抗癫痫作用。上述两味药综合作用的结果使本发明的中药具有温中、散寒、止痛的功能,对治疗血管性头痛、三叉神经痛有理想的效果。
具体实施方式:取川芎100g、荜茇80g。其制备工艺是:将以上二味药酌予碎断,加80%乙醇回流提取三次,每次2小时、分次过滤,合并滤液,并浓缩至相对密度为1.34(80℃热测)的浸膏,加入适量糖粉混合匀制成软材,过12目筛制粒,70℃烘干,整粒,装入胶囊每粒0.5g,既得。
本发明的第二个实施例,取川芎140g、荜茇40g。其制备工艺是:将以上二味药酌予碎断,加80%乙醇回流提取三次,每次2小时、分次过滤,合并滤液,并浓缩至相对密度为1.34(80℃热测)的浸膏,加入适量糖粉混合匀制成软材,过12目筛制粒,70℃烘干,整粒,装入胶囊每粒0.5g,既得。开水服用,一次2粒,一日2次。置阴凉干燥处。
本品内容物为深棕色,夹杂淡黄色的颗粒,味微苦。
鉴别
(1)取本品4g,置索氏提取器中,加适量乙醇,连续回流提取2小时,回收乙醇,残渣分别加氯仿、水各20ml充分混匀,静置,分层,弃去水层,氯仿层水浴蒸干,残渣用无水乙醇溶解,作为供试品溶液。另取胡椒碱对照品,加无水乙醇制成每1ml含4mg对照品溶液。照薄层色谱法(中国药典1995年版一部附录VIB)试验,吸取上述两种溶液各单位μl、分别点于同一硅胶G薄层板上,以苯-乙酸乙酯-丙酮(7∶2∶1)为展开剂,展开、取出,晾干。置紫外光灯(365NM)下检视,供试品色谱中,在与对照色谱相应的位置上,分别显相同的蓝色荧光斑点;喷以10%硫酸乙醇溶液,热风吹至斑点显色清晰,在日光灯下检视。供试品色谱中,在与对照品色谱相应的位置上,显相同褐黄色的斑点。
[含量测定]取本品4g,置索氏提取器中,加醋酸乙酯适量,回流提取6小时,滤过,溶液蒸干,残渣加2.5%醋酸钠60ml溶解,用苯洗涤3次,每次15ml,弃去苯层。水层加稀HCL调PH2-3,再用醋酸乙酯萃取3次,每次20ml,合并萃取液,蒸干,残渣加甲醇溶解,并移栽至5ml使容器瓶中,加甲醇至刻度,摇匀,作为供试品溶液。另取阿魏酸对照品加甲醇制成每1ml含0.4mg对照品溶液。照薄层色谱法(中国药典1995年版一部附录VIB)试验,吸取供试品溶液12μl、对照品溶液1μl、5μl分别交叉点于同一硅胶G薄层板上,以苯-乙酸乙酯-甲酸(8∶1∶1)上层为展开剂,饱和15分钟,展开、取出,晾干。在薄层板上覆盖以同样大小的玻璃板,周围用胶布固定,照薄层色谱法(中国药典95年版一部附录VIB薄层扫描法)进行扫描,波长:λs=320nm,λR=260nm,测量供试品吸收度积分值与对照品积分值,以外标两点法计算,即得。
本品含川芎按阿魏酸计算应不少于0.09mg/g。
评价本发明的中药的临床药安全性,对其进行了毒性实验研究,报告如下:
1.受试品:一种治疗头痛的中药每日2次,每次2粒。
2.试验动物:昆明种的小白鼠,体重18-22克,雌雄兼用。
3.剂量与试验药品的制备:取一种治疗头痛的中药2g,置乳钵中加10.0ml蒸馏水分散均匀,制成溶液。给药方式为灌胃给药。
一、半数致死量的测定
取小鼠9只,分三组,但未能找出100%动物死亡的剂量。选用体重20±2g的健康小鼠50只,雌雄各半,随机分为五组,一次口服
灌胃给药,剂量按等比级数,最高剂量以能够接受的最大体积计算。给药后观察7天,结果无一死亡。
二、最大耐受量试验
选择健康小鼠20只,雌雄各半,正常饲养1日后,24小时内给药2次,
间隔时间12小时,连续观察7日,未见不良反应和死亡情况,可认为该药口服无毒性。
最大耐受量倍数计算如下:
Figure A20041001363600052
如果按成人每日服2g计算,结果为正常临床剂量的240倍,说明一种治疗头痛的中药具有安全性。
                一种治疗头痛的中药临床总结
一组对血管性头痛、三叉神经痛等疾病的病人临床观察资料中的统计。
该组5%病例为观察治疗的病人。其中男子143例,女146例,年龄40-50岁58例,51-60岁210例,61岁以上21例,其中治疗方法是随机将患者分为两组,治疗组274例,服本发明的中药,每日两次,每次2粒,60天为一疗程。对照组15例,服其它药,60天为一疗程,给药前停服其它药物,治疗前后均做检查,结果表明服用本发明的中药的治疗组有效率为98%,而对照组没有明显的效果。

Claims (2)

1、一种治疗头痛的中药,其特征在于该中药由以下成份构成:川芎、荜茇,其成份的重量配比为川芎100-140份、荜茇40--80份。
2、如权利要求1所述的治疗头痛的中药,其特征在于其制备工艺是:将以上二味药酌予碎断,加80%乙醇回流提取三次,每次2小时、分次过滤,合并滤液,并浓缩至相对密度为1.34(80℃热测)的浸膏,加入适量糖粉混合匀制成软材,过12目筛制粒,70℃烘干,整粒,装入胶囊每粒0.5g,既得。
CN 200410013636 2004-03-23 2004-03-23 一种治疗头痛的中药 Expired - Lifetime CN1281234C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410013636 CN1281234C (zh) 2004-03-23 2004-03-23 一种治疗头痛的中药

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410013636 CN1281234C (zh) 2004-03-23 2004-03-23 一种治疗头痛的中药

Publications (2)

Publication Number Publication Date
CN1672697A true CN1672697A (zh) 2005-09-28
CN1281234C CN1281234C (zh) 2006-10-25

Family

ID=35045639

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410013636 Expired - Lifetime CN1281234C (zh) 2004-03-23 2004-03-23 一种治疗头痛的中药

Country Status (1)

Country Link
CN (1) CN1281234C (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552423A (zh) * 2012-02-20 2012-07-11 许从玉 一种治疗偏头痛的药物组合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552423A (zh) * 2012-02-20 2012-07-11 许从玉 一种治疗偏头痛的药物组合物

Also Published As

Publication number Publication date
CN1281234C (zh) 2006-10-25

Similar Documents

Publication Publication Date Title
US20180055903A1 (en) Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
Savych et al. Study of hypoglycemic activity of antidiabetic herbal mixture on streptozotocin-nicotinamide-induced rat model of type 2 diabetes
KR20070054222A (ko) 진통 작용이 있는 약제 조성물
EP2512444B1 (en) Mixtures of plants in spagyric mother tincture for dry cough in babies
US8945633B2 (en) Pharmaceutical composition for preventing and treating inflammatory diseases containing an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, and method for producing the fraction
CN1281234C (zh) 一种治疗头痛的中药
DE60125955T2 (de) Bioaktive fraktion von eurycoma longifolia
KR101051076B1 (ko) 개복숭아를 포함하는 알레르기 치료용 조성물 및 이의 제조방법
Nansy et al. Total flavonoid content and in vivo hypotensive effect of chloroform insoluble fraction of Centella asiatica leaf extract.
JP7005825B2 (ja) 認知症又は神経変性疾患の予防又は治療用生薬組成物
WO2014133286A1 (ko) 한인진 및 울금의 추출물을 유효성분으로 포함하는 비만 관련 질환의 예방, 억제 또는 치료용 조성물
CN111588763B (zh) 血栓通脉药物、制备方法及含量测定方法
CN1309367C (zh) 治疗胆结石的中药制剂及其制备方法
CN1704113A (zh) 治疗心脑血管疾病的中药丹红制剂及其制备方法
KR101332824B1 (ko) 민대극 추출물을 포함하는 관절염 예방 및 치료용 조성물
CN104605344A (zh) 一种增强免疫力的保健食品及其制备方法
CN1130213C (zh) 一种抗癌止痛的中药药贴
CN1293914C (zh) 改善睡眠保健药物组合物的制备工艺
CN1314425C (zh) 一种治疗类风湿性关节炎的中药
Nwoke et al. Comparative antihyperglycemic potentials of different fractions of Detarium senegalense stem bark extract on streptozotocin-induced diabetic Wistar rats
KR100846100B1 (ko) 머루 추출물을 이용한 알레르기 치료용 조성물의 제조방법및 그 조성물
CN1148182C (zh) 茶多酚在制备抑制β-淀粉样蛋白聚集和纤维形成的药物中的应用
CN1054065C (zh) 一种岩陀提取物及其作为有效成份的消炎止痛药物
Sagar et al. Formulation and Evaluation of Garlic Gel for Tongue Ulcer
WO2015124321A1 (en) Compositions for use in the treatment of mucositis and/or stomatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Wang Chunying

Document name: Notice of application for publication of patent for invention and entry into the substantive examination procedure

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Wang Chunying

Document name: Notice of first review

C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A traditional Chinese medicine for headache

Effective date of registration: 20210623

Granted publication date: 20061025

Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd.

Pledgor: HEILONGJIANG JIREN PHARMACEUTICAL Co.,Ltd.

Registration number: Y2021230000011

PC01 Cancellation of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20211019

Granted publication date: 20061025

Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd.

Pledgor: HEILONGJIANG JIREN PHARMACEUTICAL Co.,Ltd.

Registration number: Y2021230000011

PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Traditional Chinese medicine for treating headache

Effective date of registration: 20211129

Granted publication date: 20061025

Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd.

Pledgor: Heilongjiang Jiren Pharmaceutical Co.,Ltd.

Registration number: Y2021230000052

PC01 Cancellation of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20221128

Granted publication date: 20061025

Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd.

Pledgor: Heilongjiang Jiren Pharmaceutical Co.,Ltd.

Registration number: Y2021230000052

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20061025